Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KIR2DP1 (Killer cell immunoglobulin-like receptor, two domains, pseudogene 1) is a pseudogene belonging to the killer cell immunoglobulin-like receptor (KIR) gene family[1][3][4]. The KIR genes encode transmembrane glycoproteins expressed mainly on natural killer (NK) cells and some T cells, and these proteins normally regulate NK cell cytotoxic activity through interactions with MHC class I molecules[2]. However, KIR2DP1 is a pseudogene and does not encode a functional protein—it is not expressed or biologically active and thus does not act as a therapeutic target or participate directly in immune response signaling pathways[3][4]. The KIR gene family includes multiple functional receptors (both activating and inhibitory), but pseudogenes like KIR2DP1 do not contribute to protein-mediated cellular functions. The KIR nomenclature designates ‘P’ for pseudogenes[4]. Note: - This entry is considered "incorrect" as a therapeutic target because it is not a protein-coding gene nor does it have direct functional or therapeutic relevance. - While the KIR family is significant in immune regulation, KIR2DP1 itself does not have a direct role, and no drugs, biomarkers, or safety concerns are associated with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Killer cell immunoglobulin-like receptor, two domains, pseudogene 1 (KIR2DP1).